Evidence map›Paper›PMID 24916642›Full record

ArticleEuropean journal of human genetics : EJHG2015

Highly restricted deletion of the SNORD116 region is implicated in Prader-Willi Syndrome.

Eric Bieth, Sanaa Eddiry, Véronique Gaston, Françoise Lorenzini, Alexandre Buffet, Françoise Conte Auriol, Catherine Molinas, Dorothée Cailley, Caroline Rooryck, Benoit Arveiler and 3 more

Registry-linked trialOpen access · bronzeAbstract readCase Reports
In one paragraph

Article in European journal of human genetics : EJHG, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01298180 (Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?), which is not on this map. Cited by 106 papers.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed
9.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01298180 phase4completednot on this map

Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?

TypeinterventionalSponsorUniversity Hospital, ToulouseRan2009 to 2013Enrolled111ConditionsPrader-Willi Syndrome, Growth Hormone DeficiencyArmsGrowth hormone (Genotonorm® or Omnitrope®), DEXA, blood tests, H.G.P.O, osseous age., biopsy
3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 175 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Copy number evolution of conserved noncoding RNA gene families across mammals.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Genome-wide profiling of RNA 2'-bioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Light and sex modifybioRxiv : the preprint server for biology · 2025
    Article
  16. Article
  17. Loss of Snord116 protects cardiomyocyte kinetics during ischemic stress.Journal of molecular and cellular cardiology plus · 2025
    Article
  18. Article
  19. Review
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Eric BiethService de Génétique Médicale, CHU Toulouse-Purpan, Hôpital Purpan, Place du Docteur Baylac, Toulouse, France.
Sanaa EddiryCentre de Physiopathologie de Toulouse-Purpan, INSERM UMR 1043; CNRS UMR 5282, Université Paul Sabatier, Toulouse, France.
Véronique GastonService de Génétique Médicale, CHU Toulouse-Purpan, Hôpital Purpan, Place du Docteur Baylac, Toulouse, France.
Françoise Lorenzini1] Service de Diabétologie, Maladies Métaboliques et Nutrition, CHU Toulouse-Rangueil, Toulouse, France [2] Centre de Référence du Syndrome de Prader-Willi, Toulouse, France.
Alexandre BuffetService de Génétique Médicale, CHU Toulouse-Purpan, Hôpital Purpan, Place du Docteur Baylac, Toulouse, France.
Françoise Conte AuriolCentre de Physiopathologie de Toulouse-Purpan, INSERM UMR 1043; CNRS UMR 5282, Université Paul Sabatier, Toulouse, France.
Catherine Molinas1] Centre de Physiopathologie de Toulouse-Purpan, INSERM UMR 1043; CNRS UMR 5282, Université Paul Sabatier, Toulouse, France [2] Centre de Référence du Syndrome de Prader-Willi, Toulouse, France.
Dorothée CailleyUniversité Bordeaux, Maladies Rares, Génétique et Métabolisme EA4576, Service de Génétique Médicale, CHU de Bordeaux, Bordeaux, France.
Caroline RooryckUniversité Bordeaux, Maladies Rares, Génétique et Métabolisme EA4576, Service de Génétique Médicale, CHU de Bordeaux, Bordeaux, France.
Benoit ArveilerUniversité Bordeaux, Maladies Rares, Génétique et Métabolisme EA4576, Service de Génétique Médicale, CHU de Bordeaux, Bordeaux, France.
Jérome CavailléLBME UMR5099, CNRS IFR109, Toulouse, France.
Jean Pierre Salles1] Centre de Physiopathologie de Toulouse-Purpan, INSERM UMR 1043; CNRS UMR 5282, Université Paul Sabatier, Toulouse, France [2] Unité d'Endocrinologie, Hôpital des Enfants, CHU de Toulouse, Toulouse, France.
Maïthé Tauber1] Centre de Physiopathologie de Toulouse-Purpan, INSERM UMR 1043; CNRS UMR 5282, Université Paul Sabatier, Toulouse, France [2] Centre de Référence du Syndrome de Prader-Willi, Toulouse, France [3] Unité d'Endocrinologie, Hôpital des Enfants, CHU de Toulouse, Toulouse, France.
Centre Hospitalier Universitaire de Bordeaux · FRCentre National de la Recherche Scientifique · FRHôpital Purpan · FRInserm · FRHôpital Rangueil · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SNORD116 locus lies in the 15q11-13 region of paternally expressed genes implicated in Prader-Willi Syndrome (PWS), a complex disease accompanied by obesity and severe neurobehavioural disturbances. Cases of PWS patients with a deletion encompassing the SNORD116 gene cluster, but preserving the expression of flanking genes, have been described. We report a 23-year-old woman who presented clinical criteria of PWS, including the behavioural and nutritional features, obesity, developmental delay and endocrine dysfunctions with hyperghrelinemia. We found a paternally transmitted highly restricted deletion of the SNORD116 gene cluster, the shortest described to date (118 kb). This deletion was also present in the father. This finding in a human case strongly supports the current hypothesis that lack of the paternal SNORD116 gene cluster has a determinant role in the pathogenesis of PWS. Moreover, targeted analysis of the SNORD116 gene cluster, complementary to SNRPN methylation analysis, should be carried out in subjects with a phenotype suggestive of PWS.

Indexed as

Gene DeletionAdultFemaleHumansMalePrader-Willi SyndromeRNA, Small NucleolarRNA, Small NucleolarSNORD116 RNA, human

Identifiers

PMID24916642
PMCPMC4297892
OpenAlexW2076783259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.